Nouvel Hôpital Civil

Strasbourg, Alsace 67091

1 studies enrolling now · 3 studies all time

What they study most

NASH - Nonalcoholic Steatohepatitis, Patients With Non-Small Cell Lung Cancer, Primary Biliary Cholangitis

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis — Running, not enrolling
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis — Completed